Tian-Ming Jian
Tianjin Medical University Eye Hospital; Eye Institute and School of Optometry; Eye Institute; Orbital Disease and Oculoplastic Surgery Department; Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Tianjin 300384, ChinaFeng-Yuan Sun
Tianjin Medical University Eye Hospital; Eye Institute and School of Optometry; Eye Institute; Orbital Disease and Oculoplastic Surgery Department; Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Tianjin 300384, ChinaTianjin Key Clinical Discipline Construction Project(No.TJLCZDXKQ020)
Adenoid cystic carcinoma of lacrimal gland is the most common malignant epithelial tumor of the lacrimal gland, and surgical treatment alone shows unsatisfactory result. In recent years, as the application of radiotherapy and chemotherapy, changes have happened in the treatment modality for adenoid cystic carcinoma of lacrimal gland. On one hand, clinical staging is gradually refined, which promote the application of standardized comprehensive treatment. On the other hand, neoadjuvant therapies, such as proton radiotherapy, neutron radiotherapy and intra-arterial cytoreductive chemotherapy, can further improve the application of eye-sparing surgery, decrease the rate of local recurrence and metastasis, and prolong the disease-free survival. In this review, we attempt to arrive at some general insights regarding the progress of treatment in adenoid cystic carcinoma of lacrimal gland, in order to provide new reference basis.
Tian-Ming Jian, Feng-Yuan Sun. ,/et al.Development of stage and clinical treatment for adenoid cystic carcinoma of lacrimal gland. Guoji Yanke Zazhi( Int Eye Sci) 2020;20(7):1187-1191
Copy